Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Ophthalmic Devices market in Serbia is experiencing steady growth due to increasing customer preferences for advanced eye care solutions and the presence of local special circumstances. Customer preferences in the Ophthalmic Devices market in Serbia are shifting towards technologically advanced products that offer better accuracy and precision in diagnosis and treatment. This trend is driven by the growing awareness among customers about the importance of eye health and the availability of innovative ophthalmic devices in the market. Customers are seeking devices that can provide accurate measurements and help in early detection of eye diseases. Additionally, there is a growing demand for contact lenses and eyeglasses with advanced features such as UV protection and blue light filtering. Trends in the Ophthalmic Devices market in Serbia are influenced by global and regional market dynamics. The increasing prevalence of eye diseases, such as cataract, glaucoma, and refractive errors, is driving the demand for ophthalmic devices. As the population ages, the incidence of age-related eye diseases is expected to rise, leading to a higher demand for ophthalmic devices. Additionally, advancements in technology have led to the development of innovative devices, such as optical coherence tomography (OCT) scanners and femtosecond lasers, which are gaining popularity in the market. These devices offer higher precision and accuracy in diagnosing and treating eye conditions, leading to increased adoption by healthcare professionals. Local special circumstances in Serbia contribute to the growth of the Ophthalmic Devices market. The country has a well-established healthcare infrastructure, with a network of hospitals, clinics, and ophthalmic centers that provide comprehensive eye care services. This infrastructure supports the adoption of ophthalmic devices and facilitates their distribution and availability. Moreover, the Serbian government has implemented various initiatives to promote eye health and improve access to ophthalmic services, which further drives the demand for ophthalmic devices. Underlying macroeconomic factors also play a role in the development of the Ophthalmic Devices market in Serbia. The country's stable economic growth and increasing disposable income levels have led to higher healthcare spending, including investments in ophthalmic devices. Additionally, the presence of a large aging population and the rising prevalence of chronic diseases contribute to the demand for ophthalmic devices. Furthermore, Serbia's integration into the European Union has opened up opportunities for international manufacturers to enter the market and expand their presence. In conclusion, the Ophthalmic Devices market in Serbia is witnessing growth due to customer preferences for advanced eye care solutions, global and regional market trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue expanding as the demand for ophthalmic devices increases and technology advancements drive innovation in the sector.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights